SRP-9001 Gene Therapy Will File For Licensing
ADC评论
August 1, 2022
Sarepta Therapeutics Announces Intent to Submit an Accelerated Approval Biologics License Application for its Gene Therapy SRP-9001 to Treat Duchenne Muscular Dystrophy Sarepta On July
